当前位置： SCI文献检索 > AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE期刊下所有文献 > A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis.

A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis.

Abstract：

RATIONALE:Observational studies link statin therapy with improved outcomes in patients with severe sepsis. OBJECTIVES:To test whether atorvastatin therapy affects biologic and clinical outcomes in critically ill patients with severe sepsis. METHODS:Phase II, multicenter, prospective, randomized, double-blind, placebo-controlled trial stratified by site and prior statin use. A cohort of 250 critically ill patients (123 statins, 127 placebo) with severe sepsis were administrated either atorvastatin (20 mg daily) or matched placebo. MEASUREMENTS AND MAIN RESULTS:There was no difference in IL-6 concentrations (primary end point) between the atorvastatin and placebo groups (P = 0.76) and no interaction between treatment group and time to suggest that the groups behaved differently over time (P = 0.26). Baseline plasma IL-6 was lower among previous statin users (129 [87-191] vs. 244 [187-317] pg/ml; P = 0.01). There was no difference in length of stay, change in Sequential Organ Failure Assessment scores or mortality at intensive care unit discharge, hospital discharge, 28- or 90-day (15% vs. 19%), or adverse effects between the two groups. Cholesterol was lower in patients treated with atorvastatin (2.4 [0.07] vs. 2.6 [0.06] mmol/L; P = 0.006). In the predefined group of 77 prior statin users, those randomized to placebo had a greater 28-day mortality (28% vs. 5%; P = 0.01) compared with those who received atorvastatin. The difference was not statistically significant at 90 days (28% vs. 11%; P = 0.06). CONCLUSIONS:Atorvastatin therapy in severe sepsis did not affect IL-6 levels. Prior statin use was associated with a lower baseline IL-6 concentration and continuation of atorvastatin in this cohort was associated with improved survival. Clinical trial registered with the Australian New Zealand Clinical Trials Registry (ACTRN 12607000028404).

journal_name

Am J Respir Crit Care Med

journal_title

American journal of respiratory and critical care medicine

authors

Kruger P,Bailey M,Bellomo R,Cooper DJ,Harward M,Higgins A,Howe B,Jones D,Joyce C,Kostner K,McNeil J,Nichol A,Roberts MS,Syres G,Venkatesh B,ANZ-STATInS Investigators–ANZICS Clinical Trials Group.

doi

10.1164/rccm.201209-1718OC

subject

Has Abstract

pub_date

2013-04-01 00:00:00

pages

743-50

issue

eissn

1073-449X

issn

1535-4970

pii

rccm.201209-1718OC

journal_volume

187

pub_type

杂志文章,多中心研究,随机对照试验

在线工具

A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis.